Ron Bruehlman

Executive Vice President and Chief Financial Officer 

Ron E. Bruehlman

Executive Vice President and Chief Financial Officer

Ron Bruehlman has been IQVIA’s Chief Financial Officer since August 2020. He is a senior finance leader with 40 years of experience with public and private companies in the healthcare, industrial and petroleum industries.

Ron is responsible for IQVIA’s controllers, FP&A, treasury, tax, internal audit, corporate development and corporate strategy functions. From October 2016 through July 2020, he was senior advisor to IQVIA’s CEO. Prior to that, Ron was Chief Financial Officer of IMS Health from July 2011 through September 2016. He joined IMS Health following the 2010 leveraged buyout led by TPG Capital and subsequently guided the company through its 2014 IPO and its $16 billion merger with Quintiles Transnational Corporation in 2016.

Prior to joining IMS Health, Ron had a 23-year career at United Technologies Corporation, where he held multiple senior finance leadership roles of increasing responsibility. Ron began his career as a financial analyst at Conoco, Inc. (now ConocoPhillips).

Ron is a board member and Audit Committee chair for GoodRX, a leading prescription savings platform. He previously served on the boards of Atotech Ltd., Q2 Solutions (now IQVIA Biotech), Clipper Windpower, the Connecticut Forum and the New England Air Museum.

Ron earned a B.S. in economics from the University of Delaware and an MBA in finance from the University of Chicago Booth School of Business.

Contact Us